BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24335235)

  • 1. Multiple nonsteroidal anti-inflammatory drug-induced cutaneous disease: what differentiates patients with and without underlying chronic spontaneous urticaria?
    Asero R
    Int Arch Allergy Immunol; 2014; 163(2):114-8. PubMed ID: 24335235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
    Asero R
    Clin Exp Allergy; 2005 Jun; 35(6):713-6. PubMed ID: 15969659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria.
    Asero R
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):187-9. PubMed ID: 16937749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
    Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
    Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic urticaria with multiple NSAID intolerance: is tramadol always a safe alternative analgesic?
    Asero R
    J Investig Allergol Clin Immunol; 2003; 13(1):56-9. PubMed ID: 12861852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria.
    Asero R
    J Allergy Clin Immunol; 2003 May; 111(5):1095-8. PubMed ID: 12743575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.
    Zisa G; Riccobono F; Bommarito L; D'Antonio C; Calamari AM; Poppa M; Moschella MA; Di Pietrantonj C; Galimberti M
    Allergy Asthma Proc; 2012; 33(5):421-6. PubMed ID: 23026184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance.
    Asero R
    Clin Exp Dermatol; 2007 Nov; 32(6):661-3. PubMed ID: 17953635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single NSAID hypersensitivity is associated with atopic status.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):48-53. PubMed ID: 25781194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria.
    Cavkaytar O; Arik Yilmaz E; Buyuktiryaki B; Sekerel BE; Sackesen C; Soyer OU
    Allergy; 2015 Feb; 70(2):153-60. PubMed ID: 25353369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoricoxib: a safe alternative for NSAID intolerance in Asian patients.
    Llanora GV; Loo EX; Gerez IF; Cheng YK; Shek LP
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):330-3. PubMed ID: 24383977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance.
    Asero R
    Int Arch Allergy Immunol; 2007; 144(3):226-30. PubMed ID: 17579281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs.
    Nettis E; Colanardi MC; Ferrannini A; Vacca A; Tursi A
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):438-42. PubMed ID: 16312166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
    Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
    Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.
    Chaudhry T; Hissaria P; Wiese M; Heddle R; Kette F; Smith WB
    Intern Med J; 2012 Jun; 42(6):665-71. PubMed ID: 21981353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects.
    Pagani M; Bonadonna P; Dama A; Senna GE; Vescovi PP; Antico A
    Eur Ann Allergy Clin Immunol; 2010 Dec; 42(6):216-20. PubMed ID: 21287945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Viola M; Quaratino D; Gaeta F; Caruso C; Valluzzi R; Romano A
    Int Arch Allergy Immunol; 2007; 143(2):103-8. PubMed ID: 17228166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.